Business Description
Diamond Biofund Inc
ISIN : TW0006901002
Total Employee Number:
22Description
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 41.43 | |||||
Equity-to-Asset | 0.99 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.08 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Book Growth Rate | -9.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 72.67 | |||||
9-Day RSI | 72.26 | |||||
14-Day RSI | 70.4 | |||||
3-1 Month Momentum % | -10.79 | |||||
6-1 Month Momentum % | -24.85 | |||||
12-1 Month Momentum % | -39.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 56.91 | |||||
Quick Ratio | 56.91 | |||||
Cash Ratio | 56.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | 0.05 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -12.24 | |||||
ROA % | -11.98 | |||||
ROIC % | -3.01 | |||||
3-Year ROIIC % | -0.66 | |||||
ROC (Joel Greenblatt) % | -1050.88 | |||||
ROCE % | -12.09 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 1.74 | |||||
Price-to-Tangible-Book | 1.74 | |||||
EV-to-EBIT | -10.46 | |||||
EV-to-EBITDA | -10.7 | |||||
EV-to-FCF | -44.6 | |||||
| Price-to-Net-Current-Asset-Value | 4.25 | |||||
| Price-to-Net-Cash | 4.27 | |||||
Earnings Yield (Greenblatt) % | -9.56 | |||||
FCF Yield % | -1.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diamond Biofund Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | |||
| EPS (TTM) (NT$) | -1.38 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.55 | ||
| 3-Year Sortino Ratio | -1.56 | ||
| Volatility % | 59.91 | ||
| 14-Day RSI | 70.4 | ||
| 14-Day ATR (NT$) | 1.068747 | ||
| 20-Day SMA (NT$) | 16.315 | ||
| 12-1 Month Momentum % | -39.36 | ||
| 52-Week Range (NT$) | 12.05 - 21.75 | ||
| Shares Outstanding (Mil) | 852.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diamond Biofund Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diamond Biofund Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.18:1 Stock Split | 2023-08-07 | 71.27 (+3.83%) | ||
| 1.27:1 Stock Split | 2022-11-23 | 62.66 (-1.57%) |
Show
Entries
Diamond Biofund Inc Frequently Asked Questions
What is Diamond Biofund Inc(TPE:6901)'s stock price today?
The current price of TPE:6901 is NT$18.80. The 52 week high of TPE:6901 is NT$21.75 and 52 week low is NT$12.05.
When is next earnings date of Diamond Biofund Inc(TPE:6901)?
The next earnings date of Diamond Biofund Inc(TPE:6901) is .
Does Diamond Biofund Inc(TPE:6901) pay dividends? If so, how much?
Diamond Biofund Inc(TPE:6901) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Diamond Biofund Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers